Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New antithrombin-based anticoagulants.

Umesh R Desai1

  • 1Department of Medicinal Chemistry, Virginia Commonwealth University, Richmond, Virginia 23298-0540, USA. urdesai@vcu.edu

Medicinal Research Reviews
|January 6, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nascent Pre-Platelets and B4GALT1 Glycosylation Contribute to 5-FU-induced Bone Marrow Recovery.

Blood advances·2026
Same author

The excessive, opportunistic price increase of generic oncology drug floxuridine.

Journal of cancer policy·2026
Same author

Local Lung HIF-1α and VEGF Activation to Reverse Emphysema by a Sulfated Caffeic Acid Dehydropolymer.

Biology·2026
Same author

A one-step chemical derivatization strategy for mass spectrometric characterization of synthetic mimetics of sulfated glycosaminoglycans.

Analytical methods : advancing methods and applications·2026
Same author

Structural Basis of Chemokine CXCL8 Monomer and Dimer Binding to Chondroitin Sulfate: Insights into Specificity and Plasticity.

Biomolecules·2026
Same author

Targeting JNK3: An <i>In-silico</i> Approach to Uncover Potential Therapeutics for Alzheimer's Disease.

CNS & neurological disorders drug targets·2025
Same journal

Decoding the Toxicity of Synthetic Cannabinoids: From Receptor Activation to Multiorgan Dysfunction.

Medicinal research reviews·2026
Same journal

AI-Driven Synthesis in Medicinal Chemistry: Integrating Large Language Models, Robotic Automation, and Sustainability Metrics to Accelerate Drug Discovery.

Medicinal research reviews·2026
Same journal

Advances in Structural Diversity, Pharmacological Activities, and Drug Development of β-Carboline Alkaloids.

Medicinal research reviews·2026
Same journal

Small-Molecule Kinase Inhibitors Modulating Circadian Rhythms.

Medicinal research reviews·2026
Same journal

Phosphonates as Modulators of Brain Chemistry.

Medicinal research reviews·2026
Same journal

A Comprehensive Insight of Mechanisms of Drugs Targeting Ion Channels: Exemplified by Marine Natural Products and Their Analogues.

Medicinal research reviews·2026
See all related articles

New anticoagulant molecules targeting the antithrombin pathway are being developed to improve safety and efficacy over current therapies. This review highlights efforts in discovering novel antithrombotic agents, focusing on antithrombin activators.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Medicinal Chemistry

Background:

  • Current anticoagulants primarily inhibit thrombin and factor Xa, posing bleeding risks.
  • Heparin-based anticoagulants indirectly inhibit clotting enzymes by enhancing antithrombin activity.
  • There is a significant need for safer and more effective antithrombotic agents.

Purpose of the Study:

  • To review recent advancements in the discovery and design of novel anticoagulant molecules.
  • To focus on agents that modulate the antithrombin pathway of anticoagulation.
  • To explore various classes of new antithrombotic agents.

Main Methods:

  • Review of scientific literature on anticoagulant drug discovery.
  • Classification of novel anticoagulant molecules based on their mechanism and structure.

Related Experiment Videos

  • Focus on molecules acting via the antithrombin pathway.

    • Main Results:

    • Several classes of novel anticoagulants have been identified, including antithrombin mutants, modified heparins, synthetic oligosaccharides, and non-sugar antithrombin activators.
    • These agents aim to provide safer and more effective anticoagulation compared to existing therapies.
    • Significant research efforts are directed towards molecules that leverage the antithrombin pathway.

    Conclusions:

    • The development of new anticoagulant molecules targeting the antithrombin pathway holds promise for improved antithrombotic therapy.
    • Continued research into diverse classes of antithrombin activators is crucial for addressing limitations of current treatments.
    • Novel agents aim to mitigate bleeding risks associated with traditional anticoagulants.